Table 1.
Rank | Plasma miRNA | Relative levels ± SD (× 105) | Serum miRNA | Relative levels ± SD (× 105) |
1 | hsa-miR-223-3p1 | 521.3 ± 310.6 | hsa-miR-92a-3p1 | 100.2 ± 178.0 |
2 | hsa-miR-92a-3p1 | 268.7 ± 188.5 | hsa-miR-223-3p1 | 53.8 ± 24.8 |
3 | hsa-miR-20a-5p1 | 89.8 ± 38.3 | hsa-miR-451a1 | 17.6 ± 22.1 |
4 | hsa-miR-19b-3p1 | 83.2 ± 40.1 | hsa-miR-19b-3p1 | 14.7 ± 15.8 |
5 | hsa-miR-24-3p1 | 79.0 ± 44.7 | hsa-miR-20a-5p1 | 14.6 ± 14.3 |
6 | hsa-miR-30a-5p1 | 54.8 ± 31.1 | hsa-miR-30a-5p1 | 9.4 ± 11.0 |
7 | hsa-miR-451a1 | 43.3 ± 22.0 | hsa-miR-320a-3p1 | 9.3 ± 13.5 |
8 | hsa-miR-320a-3p1 | 40.1 ± 17.5 | hsa-miR-328-3p1 | 9.1 ± 3.7 |
9 | hsa-miR-484 | 36.7 ± 23.4 | hsa-miR-24-3p1 | 7.2 ± 3.2 |
10 | hsa-miR-17-5p1 | 27.2 ± 12.6 | hsa-miR-1274b | 6.4 ± 3.9 |
11 | hsa-miR-106a-5p1 | 26.0 ± 11.7 | RNU6-1 | 5.5 ± 4.0 |
12 | hsa-miR-16-5p1 | 21.2 ± 20.8 | hsa-miR-106a-5p1 | 5.4 ± 4.2 |
13 | hsa-miR-328-3p1 | 19.2 ± 5.4 | hsa-miR-16-5p1 | 5.1 ± 8.8 |
14 | hsa-miR-130a-3p | 17.5 ± 7.2 | hsa-miR-17-5p1 | 5.0 ± 3.9 |
15 | hsa-miR-30c-5p | 17.1 ± 11.6 | hsa-miR-150-5p1 | 4.0 ± 2.1 |
16 | hsa-miR-146a-5p1 | 16.2 ± 12.0 | hsa-miR-517a-3p | 2.8 ± 2.4 |
17 | hsa-miR-221-3p | 13.4 ± 7.2 | hsa-miR-30b-5p1 | 2.1 ± 1.2 |
18 | hsa-miR-150-5p1 | 13.3 ± 8.5 | hsa-miR-146a-5p1 | 1.8 ± 1.1 |
19 | has-hsa-miR-30b-5p1 | 11.5 ± 6.6 | hsa-miR-191-5p1 | 1.7 ± 0.9 |
20 | hsa-miR-191-5p1 | 10.6 ± 5.9 | hsa-miR-25-3p | 1.6 ± 2.3 |
miRNAs were common between serum and plasma.